The Cigna Group (NYSE:CI) Updates FY 2025 Earnings Guidance

The Cigna Group (NYSE:CI - Get Free Report) updated its FY 2025 earnings guidance on Saturday. The company provided EPS guidance of 29.600- for the period, compared to the consensus EPS estimate of 29.600. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on CI shares. Sanford C. Bernstein lowered shares of The Cigna Group from an "outperform" rating to a "market perform" rating and set a $323.00 price objective on the stock. in a research report on Thursday, February 6th. UBS Group reduced their price target on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, February 3rd. Cantor Fitzgerald increased their price objective on The Cigna Group from $350.00 to $365.00 and gave the stock an "overweight" rating in a research note on Thursday, March 20th. Guggenheim restated a "buy" rating and issued a $388.00 price target (up previously from $384.00) on shares of The Cigna Group in a report on Monday, May 5th. Finally, Truist Financial raised their price target on shares of The Cigna Group from $385.00 to $405.00 and gave the company a "buy" rating in a report on Monday. Two analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and three have issued a strong buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Buy" and a consensus price target of $379.33.

The Cigna Group Stock Down 2.6%

NYSE:CI traded down $8.14 during trading hours on Tuesday, hitting $307.60. The company's stock had a trading volume of 573,536 shares, compared to its average volume of 1,700,331. The stock has a fifty day moving average of $325.94 and a 200-day moving average of $310.00. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The stock has a market capitalization of $82.17 billion, a P/E ratio of 25.09, a price-to-earnings-growth ratio of 0.98 and a beta of 0.47. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83.

The Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.35 by $0.39. The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. The business had revenue of $65.45 billion for the quarter, compared to analyst estimates of $60.39 billion. During the same period last year, the firm posted $6.47 earnings per share. The company's revenue for the quarter was up 14.4% compared to the same quarter last year. On average, equities analysts forecast that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Stockholders of record on Tuesday, June 3rd will be issued a $1.51 dividend. The ex-dividend date of this dividend is Tuesday, June 3rd. This represents a $6.04 annualized dividend and a dividend yield of 1.96%. The Cigna Group's dividend payout ratio is currently 33.44%.

Insiders Place Their Bets

In other news, CEO David Cordani sold 26,527 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $8,173,499.24. Following the sale, the chief executive officer now owns 127,767 shares of the company's stock, valued at $39,367,568.04. The trade was a 17.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Nicole S. Jones sold 4,904 shares of the business's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total value of $1,511,020.48. Following the sale, the insider now owns 29,421 shares in the company, valued at approximately $9,065,198.52. The trade was a 14.29% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 43,751 shares of company stock worth $13,603,991. Corporate insiders own 0.70% of the company's stock.

Institutional Inflows and Outflows

An institutional investor recently raised its position in The Cigna Group stock. Brighton Jones LLC grew its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 9.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,736 shares of the health services provider's stock after buying an additional 318 shares during the quarter. Brighton Jones LLC's holdings in The Cigna Group were worth $1,032,000 at the end of the most recent quarter. Institutional investors and hedge funds own 86.99% of the company's stock.

The Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.